Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
11.50
-0.13 (-1.12%)
At close: Sep 2, 2026, 4:00 PM EDT
11.58
+0.08 (0.70%)
Pre-market: Sep 3, 2026, 5:26 AM EDT
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.95 billion as of September 2, 2026. Its market cap has increased by 183.57% in one year.
Market Cap
1.95B
Enterprise Value
1.51B
1-Year Change
183.57%
Ranking
Category
Stock Price
$11.50
ChartMarket Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has increased from $1.53B to $1.95B, an increase of 26.88%. That is a compound annual growth rate of 3.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.95B | 131.96% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 2.08B |
| Xencor | 2.08B |
| Vericel | 2.07B |
| Hemab Therapeutics Holdings | 2.06B |
| Agios Pharmaceuticals | 2.04B |
| Generate Biomedicines | 2.03B |
| Stoke Therapeutics | 1.99B |
| Nanobiotix | 1.97B |